Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma
NCT04305470
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class
Conditions
Meningioma
Interventions
DRUG:
Gleolan
Sponsor
NX Development Corp